The effectiveness of zofenopril in patients with cardiovascular disease

Кукес, В. Г.; Григорьевич, Кукес Владимир; Anikin, G S; Станиславович, Аникин Георгий

doi:10.26442/2075-082x_11.2.59-62

Syst Hypertens

2014

DOI: 10.26442/2075-082x_11.2.59-62

|View full text |Cite

The effectiveness of zofenopril in patients with cardiovascular disease

В. Г. Кукес¹,

Кукес Владимир Григорьевич²,

G S Anikin³

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2016

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Features of zofenopril and enalapril in patients with stable ischemic heart disease in combination with arterial hypertension

Евдокимова

Г²,

Сметанин

et al. 2016

CardioSomatics

View full text Add to dashboard Cite

Objective. Optimization of drug therapy in patients with stable coronary heart disease and arterial hypertension (AH) in the application of ACE inhibitors: zofenopril compared with enalapril. Material and methods. We studied 80 patients with stable angina II-III functional class (FC) and AG 1-2 degree (Mean age 58.8±8.8 years) who were randomly divided into 2 groups of observation for 40 people in each: 1 - receiving zofenopril, 2 - enalapril - composed of basic therapy consisting of nitrates, .-blocker, statin, aspirin. The duration of follow-up was 6 months. At baseline and in the dynamics of all patients underwent clinical, laboratory and instrumental studies. It evaluated the quality of life through «Seattle questionnaire» for patients with angina. The daily monitoring of blood pressure at the same time with an electrocardiogram, treadmill test according to the modified protocol R.Bruce, echocardiography was conducted. Conclusion. The use of zofenopril, more than enalapril leads to significantly improved quality of life, exercise tolerance, normalizes the diurnal profile of blood pressure, reduces episodes of ischemia.

show abstract

Features of zofenopril and enalapril in patients with stable ischemic heart disease in combination with arterial hypertension

Евдокимова

Г²,

Сметанин

et al. 2016

CardioSomatics

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

The effectiveness of zofenopril in patients with cardiovascular disease

Cited by 1 publication

References 0 publications

Features of zofenopril and enalapril in patients with stable ischemic heart disease in combination with arterial hypertension

Features of zofenopril and enalapril in patients with stable ischemic heart disease in combination with arterial hypertension

Contact Info

Product

Resources

About